✨ Medicines Consent Notices
10 MARCH 2011 NEW ZEALAND GAZETTE, No. 26 769
Schedule
Product:
Codral Relief Mucus Cough & Cold
Active Ingredients:
Guaifenesin 20mg/mL
Phenylephrine hydrochloride 1mg/mL
Dosage Form:
Oral solution
New Zealand Sponsor:
Johnson & Johnson (New Zealand) Limited
Manufacturer:
Probiotec Pharma Pty Limited, Laverton North, Australia
Product:
Desitin® Rapid Relief
Active Ingredient:
Zinc oxide 40%w/w
Dosage Form:
Topical ointment
New Zealand Sponsor:
Johnson & Johnson (New Zealand) Limited
Manufacturer:
McNeill PPC Inc., Pennsylvania, United States of America
Product:
Neutrogena Blackhead Eliminating Daily Scrub
Active Ingredient:
Salicylic acid 2%w/w
Dosage Form:
Skin wash
New Zealand Sponsor:
Johnson & Johnson (New Zealand) Limited
Manufacturer:
Neutrogena Corporation, Los Angeles, United States of America
Product:
Octalbin
Active Ingredient:
Albumin 50g/L
Dosage Form:
Solution for infusion
New Zealand Sponsor:
Octapharma New Zealand Limited
Manufacturer:
Octapharma Pharmazeutika Produktions GmbH, Vienna, Austria
Product:
Octalbin
Active Ingredient:
Albumin 200g/L
Dosage Form:
Solution for infusion
New Zealand Sponsor:
Octapharma New Zealand Limited
Manufacturer:
Octapharma Pharmazeutika Produktions GmbH, Vienna, Austria
Product:
Pharmacist’s Own Cold & Flu Relief PE
Active Ingredients:
Codeine phosphate hemihydrate 6mg
Paracetamol 500mg
Phenylephrine hydrochloride 5mg
Dosage Form:
Tablet
New Zealand Sponsor:
PSM Healthcare Limited trading as API Consumer Brands
Manufacturer:
PSM Healthcare Limited trading as API Consumer Brands, Auckland, New Zealand
Dated this 3rd day of March 2011.
MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go1505
Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product:
Blackmores Macu-Vision
Active Ingredients:
Ascorbic acid 250mg
Cupric oxide 1.25mg equivalent to 1mg copper
D-alpha-Tocopheryl acid succinate 165mg equivalent to 200IU vitamin E
Zinc oxide 49.8mg equivalent to 40mg zinc
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Blackmores Limited
Manufacturer:
Catalent Australia Pty Limited, Braeside, Australia
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 3rd day of March 2011.
MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go1508
Next Page →
✨ LLM interpretation of page content
🏥
Consent to the Distribution of New Medicines under the Medicines Act 1981
(continued from previous page)
🏥 Health & Social Welfare3 March 2011
Medicines, Distribution, Consent, Codral Relief Mucus Cough & Cold, Desitin® Rapid Relief, Neutrogena Blackhead Eliminating Daily Scrub, Octalbin, Pharmacist’s Own Cold & Flu Relief PE
- MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation, Ministry of Health
🏥 Provisional Consent to the Distribution of a New Medicine
🏥 Health & Social Welfare3 March 2011
Medicines, Provisional Consent, Blackmores Macu-Vision
- MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation, Ministry of Health
NZ Gazette 2011, No 26